|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Vinyl chloride | CAS 75-01-4 | ||
| CH2=CHCl | RTECS KU9625000 | ||
|
Synonyms & Trade Names Chloroethene, Chloroethylene, Ethylene monochloride, Monochloroethene, Monochloroethylene, VC, Vinyl chloride monomer (VCM) |
DOT ID & Guide 1086 116P |
||
|
Exposure Limits |
NIOSH REL: Ca See Appendix A | ||
| OSHA PEL: [1910.1017] TWA 1 ppm C 5 ppm [15-minute] | |||
| IDLH Ca [N.D.] | Conversion 1 ppm = 2.56 mg/m3 | ||
|
Physical Description Colorless gas or liquid (below 7°F) with a pleasant odor at high concentrations. [Note: Shipped as a liquefied compressed gas.] |
|||
|
MW: 62.5 |
BP: 7°F |
FRZ: -256°F |
Sol(77°F): 0.1% |
|
VP: 3.3 atm |
IP: 9.99 eV |
RGasD: 2.21 |
|
|
Fl.P: NA (Gas) |
UEL: 33.0% |
LEL: 3.6% |
|
| Flammable Gas | |||
|
Incompatibilities & Reactivities Copper, oxidizers, aluminum, peroxides, iron, steel [Note: Polymerizes in air, sunlight, or heat unless stabilized by inhibitors such as phenol. Attacks iron & steel in presence of moisture.] |
|||
|
Measurement Methods NIOSH 1007; OSHA 4, 75 |
|
Personal Protection & Sanitation Skin: Frostbite Eyes: Frostbite Wash skin: No recommendation Remove: When wet (flammable) Change: No recommendation Provide: Frostbite |
First Aid (See procedures) Eye: Frostbite Skin: Frostbite Breathing: Respiratory support |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted canister providing protection against the compound of concern/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin, and/or eye contact (liquid) | |
| Symptoms Lassitude (weakness, exhaustion); abdominal pain, gastrointestinal bleeding; enlarged liver; pallor or cyanosis of extremities; liquid: frostbite; [potential occupational carcinogen] | |
|
Target Organs
Liver, central nervous system, blood, respiratory system, lymphatic system Cancer Site [liver cancer] |
|
| See also: INTRODUCTION |